Skip to main content
Julie Gerberding, MD, Infectious Disease, San Francisco, CA

JulieLouiseGerberdingMD

Infectious Disease San Francisco, CA

Past Director, Centers for Disease Control

Are you Dr. Gerberding?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 42 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    1001 Potrero Avenue
    Bldg 30 4th Floor
    San Francisco, CA 94110
    Phone+1 415-206-5438
    Fax+1 415-648-8425

Summary

  • Dr. Julie Gerberding, MD is an infectious disease specialist in San Francisco, California. She is currently licensed to practice medicine in California and Georgia. She is a Past Director at Centers for Disease Control.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1981 - 1986
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1981

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1983 - 2026
  • GA State Medical License
    GA State Medical License 1999 - 2003
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2004

Publications & Presentations

PubMed

Press Mentions

  • FNIH Biomarkers Consortium Announces Study Results Further Validating Blood Tests for Alzheimer’s Disease
    FNIH Biomarkers Consortium Announces Study Results Further Validating Blood Tests for Alzheimer’s DiseaseJuly 28th, 2024
  • Bespoke Gene Therapy Consortium Selects 8 Rare Diseases for Clinical Trial Portfolio
    Bespoke Gene Therapy Consortium Selects 8 Rare Diseases for Clinical Trial PortfolioMay 17th, 2023
  • Why Mississippi, a Covid Hot Spot, Left Millions in Pandemic Aid Unspent
    Why Mississippi, a Covid Hot Spot, Left Millions in Pandemic Aid UnspentFebruary 13th, 2023
  • Join now to see all